Changchun High-tech Zone: Focusing on traditional advantageous fields such as endocrine metabolism and innovation directions, more than 40 candidate drugs are in clinical stages or have already submitted IND.

Changchun High-tech responded on the investor interaction platform that, in order to continuously enhance the company's core competitiveness, the company is focusing on traditional areas of endocrine metabolism, women's health, as well as innovative directions in tumors, respiratory, and immune-related areas. The company is steadily advancing research and development work on products with differentiation and global market potential. Currently, there are over 40 candidate drugs in clinical stages or have already submitted applications for new drug clinical trials.